# INFORMATION VS MODEL REVISION REPORT

A. Final title: Disentangling protein-information gain and model-specific reliability in CITE-seq representation learning

   Alternative titles:
   1. Separating multimodal information gain from model-specific advantage in CITE-seq representation learning
   2. Protein information and model-specific reliability in CITE-seq representation learning

B. Central research question: How much of the gain from multimodal CITE-seq comes from access to protein information itself, and when does a complex multimodal model provide reliable additional value beyond a simple multimodal representation?

C. Internal information gain G_info = concat − RNA PCA = 0.745 − 0.666 = +0.079

D. Internal model-specific gain G_model = totalVI − concat = 0.779 − 0.745 = +0.034

E. Percentage of RNA-PCA-to-totalVI gap descriptively recovered by concat: ≈70% (0.079/0.113). Language is descriptive, not causal.

F. Existing inductive concat transfer: Direction A ≈ 0.735; Direction B ≈ 0.734 (preserved source-fitted inductive baselines).

G. New target-data-access-matched transductive concat: Direction A ≈ 0.636; Direction B ≈ 0.767.

H. scVI/totalVI transfer (scArches): Dir A scVI 0.656±0.018 / totalVI 0.652±0.015; Dir B scVI 0.601±0.020 / totalVI 0.654±0.025 (Δ+0.052; 19/20 seeds).

I. Whether target-data matching changes interpretation: YES — Case C. Matching unlabeled-target feature access reverses/weakens residual totalVI advantage relative to simple concat (Dir A totalVI−transductive concat ≈ +0.016; Dir B ≈ −0.113). Inductive concat vs scArches must not be read as a pure architecture comparison.

J. Whether totalVI retains a model-specific transfer advantage anywhere: YES, but narrowly — vs scVI in Direction B (+0.052, 19/20); vs matched transductive concat only a small +0.016 in Direction A and a clear disadvantage in Direction B. Residual advantage is source–target dependent (Case C).

K. Lawlor donor-level totalVI−scVI: mean Δ ≈ +0.090; 10/10 donors positive; between-donor SD ≈ 0.010. Latent consistency 38/50 fold×seed pairs (computational).

L. Lawlor protein PCA / concat: protein PCA ≈ 0.927; concat PCA ≈ 0.945; totalVI ≈ 0.888.

M. Exact wording for Lawlor label-modality alignment: "protein-gated author labels" / "author labels are protein-gated" (Results, Methods, Figure 6 legend, Discussion).

N. Manuscript clearly distinguishes information gain from model-specific gain: YES (G_info / G_model defined; Figure 1–2; Abstract; Methods subsection).

O. Uncertainty / stochasticity / degradation framed as stress tests of residual model-specific advantage: YES.

P. Claims of universal architecture superiority remaining: NO (banned/replaced; Lawlor explicitly not architecture ranking).

Q. New external dataset required for application manuscript: NO. Discussion notes optional future cohort with protein-independent labels.

R. Final DOCX path: results/final_information_vs_model_manuscript/manuscript/CITEseq_Information_vs_Model_Reliability_Research_Manuscript.docx

---
Abstract word count: 218
DOCX validation: {"title_ok": true, "unpublished": true, "no_zenodo": true, "no_phase": true, "g_info": true, "g_model": true, "seventy_pct_descriptive": true, "matched_transductive": true, "inductive_preserved": true, "case_c": true, "protein_gated": true, "lawlor_donors": true, "protein_pca_lawlor": true, "concat_lawlor": true, "latent_38_50": true, "rna_audit": true, "n_images": 6, "n_tables": 6, "n_paragraphs": 132, "no_github_ssh": true, "no_1920_on_lawlor": true, "has_1920": true}
Historical PHASE 6–14 / revision_round2 P0–P1 artifacts: not overwritten.
Matched transfer outputs: results/revision_round3_information_vs_model/transfer_control/

STOP: no commit, push, MultiVI, missing-modality, new external cohort, or journal submission.
